ArticleCureus2025
A Longitudinal Prospective Study of Active Tuberculosis Among Patients in Tétouan, Morocco.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTuberculosis (TB) continues to be a significant global health challenge, particularly in developing countries. Tétouan, Morocco, is among the most affected cities in the country; however, limited information is available on the impact of TB and its treatment on various aspects of patients' lives. This study aims to comprehensively analyze the clinical, microbiological, nutritional, and psychosocial characteristics of patients undergoing intensive pulmonary TB treatment in Tétouan.
methodsWe conducted a 1.5-year prospective study on patients with bacteriologically confirmed pulmonary TB during the intensive treatment phase. Clinical, social, psychological, and nutritional data were collected, and bacteriological monitoring was performed. Statistical analysis was conducted using SPSS software (IBM Corp., Armonk, NY), with a 95% significance level.
resultsAmong the 125 surveyed patients (mean age: 37.5 years, male-to-female ratio: 3.8), 91 (73.2%) resided in urban areas, 19 (15.4%) had difficulties reaching a healthcare center, and 89 (71%) were newly diagnosed. Side effects were reported by 121 patients (97%), primarily muscle and joint pain. A balanced diet was maintained by 80 patients (63.9%) during treatment. Anxiety was observed in 102 patients (82%) and correlated with female gender, retreatment cases, smoking, side effects, and living in urban areas. Depression was experienced by 113 patients (91%), significantly associated with smoking, side effects, and retreatment cases. The sputum conversion rate was low (62.4%) and showed a significant correlation with symptom progression after two months of intensive treatment.
conclusionConsistent patient support throughout the entire treatment period is crucial to preventing dropout and treatment failure. Greater efforts are needed to strengthen economic, social, and psychological support for patients. Healthcare educational units play a key role in informing patients about nutrition, potential side effects, and nicotine withdrawal symptoms. These interventions are essential to enhancing adherence and improving overall treatment outcomes in Tétouan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.